Speaker| Dr Vladimir Mironov, Laboratory of Biotechnology Research of 3D Bioprinting Solutions & Regenerative Medicine Institute of Sechenov Medical University, Moscow, Russia

Date| 10 September 2019 (Tuesday)

Time| 1000 – 1100

Venue| 2.305 Think Tank 20, Building 2 Level 3


Organ printing could be defined as automated robotic layer by layer additive biofabrication of 3D functional tissue and organ constructs using tissue spheroids as building blocks according to digital model. Organ printing has certain advantages: it is an automated approach that offers a pathway for scalable reproducible mass production of tissue engineered products; it allows a precised simultaneous 3D positioning of several cell types; it enables creation tissue with a high level of cell density; it can solve the problem of vascularization in thick tissue constructs; finally, organ printing can be done in situ. The main practical outcomes of organ-printing technology are industrial scalable robotic biofabrication of complex human tissues and organs, automated tissue-based in vitro assays for clinical diagnostics, drug discovery and drug toxicity, and complex in vitro models of human diseases. New trends in 3D bioprinting technology (Hybrid biofabrication, in situ bioprinting, 4D bioprinting,  magneto-acoustic levitational bioassembly as well as Bioprinting in Space) will be presented and discussed.



Vladimir Mironov was born in Russia in 1954. Vladimir Mironov finished Ivanovo State Medical Institute in 1977 as a medical doctor. He got his PhD in Developmental Biology from Second Moscow Pirogov Medical Institute in 1980. He was trained by Prof. Peter Kaufmann at The Department of Anatomy RWTH in Aachen and Werner Risau’s lab in Germany in Max Planck Institute for Psychiatry in Matinsried, Germany. He later worked at The Department of Anatomy and Regenerative Medicine and Advanced Tissue Biofabrication Center in The Medical University of South Carolina in Charleston, SC, USA and then at The Division of 3D Technologies of Renato Archer Institute for Information Technology at Campinas, SP, Brazil. Last 5 years he worked as a Chief Scientific Officer at 3D Bioprinting Solutions and Leading Scientist at Regenerative Medicine institute of Moscow Sechenov Medical University, Moscow, Russia. He is one of pioneer of 3D bioprinting technology. He already bioprinted a first functional and vascularized organ construct – a mouse thyroid gland. He got 2018 Senior Investigator Award from International Society for Biofabrication.